Advanced Search

Ordinance Amending The Ordinance On Veterinary Use, Dispensing And Prescribing Of Medicines For Animals

Original Language Title: Bekendtgørelse om ændring af bekendtgørelse om dyrlægers anvendelse, udlevering og ordinering af lægemidler til dyr

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$40 per month.

Publication of the amendment of the notice of the use, extradition and prescribing of medicinal products for animals 1)

§ 1

Notice no. 482 of 29. In May 2007 concerning the use, extradition and prescribing of medicinal products for animals, the following changes shall be made :

1. § 5 ITREAS :

" § 5. For therapeutic treatment, cf. sections 13 and 14 mean the individual submission to food-producing animals of a medicinal product of :

1) Beta-agonists for horses with the following purposes :

a) treatment of respiratory problems,

b) the treatment of hovsenebenitis,

c) the processing of the conception, or

d) convelition of vegliing (tocolyse).

2) Allyeneenbolon (altrenogest) to heat control of competition-or circushest.

3) The progesterone and derivatives, which, by the hydrolysis, form the original connection after absorption from the place of administration, to the treatment of disturbances in the ovarian. `

2. I Section 9 (1). 1, the following shall be added after ' to : 'food-producing'.

3. Section 9 (1). 2, revoked.

4. § 13 ITREAS :

" § 13. Therapeutic treatment, as mentioned in section 5, no. 1 and 3 are permitted on condition that :

1) treatment is carried out by the veterinarian personally,

2) the treatment cf. § 5, nr. 3, only in the form of injections or vaginal cycle on uniquely identified food-producing animals,

3) only medicinal products which comply with the conditions laid down in section 8 (2) are used. Paragraph 1, or Article 8 (3). 2, no. 1 2, and which have a detention time of not more than 15 days, for beta-agonists not more than 28 days, and

4) the veterinarian shall make a record in accordance with section 34 (1). 1.

Paragraph 2. For the post-treatment of a horse treated in accordance with paragraph 1. 1, with beta-agonists against respiratory problems, the main inflammation or laminitis, the veterinarian may extradite or prescribe prescription medicinal products containing beta-agonists, on condition that :

1) the treatment is carried out under the responsibility of the veterinarian ;

2) the prescribed medicinal products or prescribed medicinal products satisfy the conditions laid down in section 8 (3). Paragraph 1, or Article 8 (3). 2, no. 1-2, is for submission through the mouth and has a withdrawal period of not more than 28 days,

3) the veterinarian shall make a record in accordance with section 34 (1). 1, and

4) the veterinarian shall enter the date of initiation and termination of the treatment. `

5. I § 14 change ' § 5, nr. 3 "to :" § 5, nr. TWO. "

6. Appendix 3 ITREAS :

" List A : Offered substances

Thyreostatics

Stillbenes, stilts derivatives, salts and esters

Østradiol 17 beta and ester-like derivatives thereof

List B : Prohibied substances with exceptions

Beta-agonists. "

§ 2

The announcement shall enter into force on 1. January, 2009.

The FDA, the 15th. December 2008 Anders Munk Jensen / Tom Kaadtmann Buck
Official notes

1) The commotion contains provisions that implement parts of Directive 2008 /97/EC of the European Parliament and of the Council amending Council Directive 96 /22/EEC of 29. April 1996 banning the use of certain substances having a hormonal and thyrostatic action and of beta-agonists in animal hushushuss.